Literature DB >> 12023365

IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor alpha promoter.

Jennifer M Mariner1, Yael Mamane, John Hiscott, Thomas A Waldmann, Nazli Azimi.   

Abstract

IL-15Ralpha mRNA and protein levels are increased in human T cell lymphotropic virus type-I (HTLV-I)-associated adult T cell leukemia. Previously, we demonstrated that IL-15Ralpha expression was activated by HTLV-I Tax, in part, through the action of NF-kappaB. However, there appeared to be additional motifs within the IL-15Ralpha promoter that were responsive to HTLV-I Tax. In this study, we demonstrated that IL-15Ralpha mRNA expression was activated in human monocytes by IFN treatment, suggesting a role for IFN regulatory factors (IRFs) in IL-15Ralpha transcription. In addition, an IRF element within the Tax-responsive element of the IL-15Ralpha promoter was necessary for maximal Tax-induced activation of this promoter. Furthermore, we demonstrated that IRF-4, a transcription factor known to be elevated in HTLV-I-infected cells, activated the IL-15Ralpha promoter. Inhibition of IRF-4 action lead to reduced Tax-induced activation of the IL-15Ralpha promoter, while inhibition of both IRF-4 and NF-kappaB severely inhibited the Tax-induced activation of this promoter. These findings suggest a role for both NF-kappaB and IRF-4 in the transcriptional regulation of IL-15Ralpha by HTLV-I Tax. It is possible that the HTLV-I Tax-mediated induction of IL-15Ralpha and IL-15 may lead to an autocrine cytokine-mediated stimulatory loop leading to the proliferation of HTLV-I infected cells. This loop of proliferation may facilitate viral propagation and play a role in HTLV-I-mediated disease progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023365     DOI: 10.4049/jimmunol.168.11.5667

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Survival adjustment of mature dendritic cells by IL-15.

Authors:  Sigrid P Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

2.  Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.

Authors:  Nazli Azimi; Steven Jacobson; Yuetsu Tanaka; Lawrence Corey; Veronika Groh; Thomas Spies
Journal:  Immunogenetics       Date:  2006-03-28       Impact factor: 2.846

3.  IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.

Authors:  Shinichiro Yokota; Osamu Yoshida; Lei Dou; Anthony V Spadaro; Kumiko Isse; Mark A Ross; Donna B Stolz; Shoko Kimura; Qiang Du; Anthony J Demetris; Angus W Thomson; David A Geller
Journal:  J Immunol       Date:  2015-05-11       Impact factor: 5.422

4.  Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells.

Authors:  Jürgen R Müller; Thomas A Waldmann; Michael J Kruhlak; Sigrid Dubois
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

Review 5.  IRF4: Immunity. Malignancy! Therapy?

Authors:  Arthur L Shaffer; N C Tolga Emre; Paul B Romesser; Louis M Staudt
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

6.  Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells.

Authors:  Mariko Mizuguchi; Hironobu Asao; Toshifumi Hara; Masaya Higuchi; Masahiro Fujii; Masataka Nakamura
Journal:  J Biol Chem       Date:  2009-07-17       Impact factor: 5.157

7.  Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells.

Authors:  Michael Lohoff; Hans-Willi Mittrücker; Anne Brüstle; Frank Sommer; Bärbel Casper; Magda Huber; David A Ferrick; Gordon S Duncan; Tak W Mak
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.